Sheba Medical Center and Synchrony Medical Initiate a First Clinical Trial Using a Personalized Chest Physiotherapy System for Patients Living with Chronic Lung Diseases
USA - English
Share this article
Share this article
OR YEHUDA, Israel, April 6, 2021 /PRNewswire/ Synchrony Medical, a medical device company developing a personalized chest physiotherapy system designed to provide efficient airway clearance, has recently initiated a clinical trial at The National Cystic Fibrosis Center of Israel, at Sheba Medical Center.
The trial aims to test the functionality of the system and compare its airway clearance effectiveness to standard of care solutions currently used in Cystic Fibrosis and Bronchiectasis patients.
Eltek Reports Full Year and Fourth Quarter 2020 Financial Results
Eltek Ltd., a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced its financial results for the full year and fourth quarter ended December 31, 2020.
Eli Yaffe, Chief Executive Officer, commented, We are pleased with the growth in our revenues and profitability in the fourth quarter and the significant change in our full year results. The improved results reflect the growth in our revenues and the continued improved operating efficiencies.”
Eltek has managed successfully through the COVID pandemic in 2020 because of the following actions:
Eltek’s balance market sectors strategy enabled Eltek to mitigate the downturn in the commercial aerospace market through its involvement in the defence market and the medical devices market.
COVID-19 disrupts Hartford s efforts to become a startup magnet hartfordbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hartfordbusiness.com Daily Mail and Mail on Sunday newspapers.
Israel Biotech Fund closes $112m second fund
IBF focuses on investments in drug development and medical diagnostics companies in all stages.
Israel Biotech Fund (IBF) has closed its $112 million second fund. The fund was founded by managing partners Dr. David Sidransky, Dr. Yuval Cabilly, and Ido Zairi. The main investors in the second fund include Harel Insurance Investments and Financial Services Ltd. (TASE: HARL), pharmaceutical giant Bristol Myers Squibb (BMS) and the CBG Capital private equity fund.
IBF s second fund is larger than its first fund, which amounted to $70 million, and slightly larger than the amount that it set out to raise.
Jerusalem College of Technology Graduates Win Government Contract to Use Drones in Deliveries | The Jewish Press - JewishPress com | Jewish Press News Desk | 23 Nisan 5781 – April 5, 2021 jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.